1. 1282. Safety, Tolerability, and Pharmacokinetics of BRII-732, A Medoxomil Carbonate Prodrug of Islatravir in Healthy Adult Subjects. (15th December 2022) Authors: Margolis, David A; Ma, Ji; Watkins, Michael; Wang, Yujin; Trivedi, Chetana; Peng, Chi-Chi; Wei, Xuelian; Zhong, Lijie; Patel, Kamlesh; Girardet, Jean-Luc; Wang, Michael; VonderEmbse, Annalise; Yan, Li; Hong, Zhi; Xu, Lianhong Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1283. Safety, Tolerability, and Pharmacokinetics of BRII-778, A Modified-Release Oral Formulation of Rilpivirine in Healthy Adult Subjects. (15th December 2022) Authors: Margolis, David A; Ma, Ji; Watkins, Michael; Wang, Yujin; Trivedi, Chetana; Wei, Xuelian; Zhong, Lijie; Patel, Kamlesh; Yan, Li; Hong, Zhi; Girardet, Jean-Luc; Xu, Lianhong Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial. Issue 5 (May 2022) Authors: Self, Wesley H.; Sandkovsky, Uriel; Reilly, Cavan S.; Vock, David M.; Gottlieb, Robert L.; Mack, Michael; Golden, Kevin; Dishner, Emma; Vekstein, Andrew; Ko, Emily R.; Der, Tatyana; Franzone, John; Almasri, Eyad; Fayed, Mohamed; Filbin, Michael R.; Hibbert, Kathryn A.; Rice, Todd W.; Casey, Jonat... Journal: Lancet infectious diseases Issue: Volume 22:Issue 5(2022) Page Start: 622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Erratum to: Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney. Issue 1 (December 2016) Authors: Miner, Jeffrey; Tan, Philip; Hyndman, David; Liu, Sha; Iverson, Cory; Nanavati, Payal; Hagerty, David; Manhard, Kimberly; Shen, Zancong; Girardet, Jean-Luc; Yeh, Li-Tain; Terkeltaub, Robert; Quart, Barry Journal: Arthritis research & therapy Issue: Volume 18:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney. Issue 1 (December 2016) Authors: Miner, Jeffrey; Tan, Philip; Hyndman, David; Liu, Sha; Iverson, Cory; Nanavati, Payal; Hagerty, David; Manhard, Kimberly; Shen, Zancong; Girardet, Jean-Luc; Yeh, Li-Tain; Terkeltaub, Robert; Quart, Barry Journal: Arthritis research & therapy Issue: Volume 18:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney. Issue 1 (December 2016) Authors: Miner, Jeffrey; Tan, Philip; Hyndman, David; Liu, Sha; Iverson, Cory; Nanavati, Payal; Hagerty, David; Manhard, Kimberly; Shen, Zancong; Girardet, Jean-Luc; Yeh, Li-Tain; Terkeltaub, Robert; Quart, Barry Journal: Arthritis research & therapy Issue: Volume 18:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗